Search / Trial NCT06234722

Modeling Tobacco Regulatory Impacts in Appalachia Using the Experimental Tobacco Marketplace

Launched by MIKHAIL N KOFFARNUS · Jan 22, 2024

Trial Information

Current as of October 07, 2024

Enrolling by invitation

Keywords

Description

After granting informed consent, participants will complete a baseline assessment session. This will be followed by an extended 9-week sampling period to acclimate participants to their randomly assigned experimental cigarette and allow any shifts in product consumption patterns to materialize. In the final week of this sampling period, participants will complete behavioral assessments and a series of assessments to assess the impact of potential regulatory environments relevant to our aims. Experimental Tobacco Marketplace. In this procedure, participants will complete purchasing scenario...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * At least 21 years old
  • * Consume nicotine and/or tobacco products daily
  • * Have no plans to quit nicotine/tobacco consumption or seek treatment in the subsequent 9 weeks
  • * Read and understand English
  • Exclusion Criteria:

About Mikhail N Koffarnus

Mikhail N. Koffarnus is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative therapeutic interventions. With a strong background in clinical pharmacology and a commitment to rigorous scientific methodology, Koffarnus leads and oversees a diverse portfolio of clinical trials. His expertise encompasses the design, implementation, and management of studies that explore novel treatment options across various therapeutic areas. By fostering collaboration among multidisciplinary teams and prioritizing ethical standards, Mikhail N. Koffarnus aims to contribute significantly to the advancement of healthcare and the discovery of effective medical solutions.

Locations

Lexington, Kentucky, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0